Company / Financials
Cytosorbents Corp Financials
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$4.9M
FY2018 · -67.5% YoY
Net Income
-$17.2M
FY2018 · -103.4% YoY
Profit Margin
-349.5%
FY2018 · net income / revenue
ROE
-101.6%
FY2018 · return on equity
Total Assets
$34.2M
FY2018
Total Debt
$9.9M
0.59x debt/equity
Equity
$16.9M
FY2018
ROA
-50.3%
FY2018 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$4.9M-67.5% YoYNet Income HistoryProfit after all expenses and taxes-$17.2M-103.4% YoYGross Profit HistoryRevenue minus cost of goods sold$15.0M+55.9% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$7.5M+35.7% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$15.6M-58.3% YoYSG&A Expense HistorySelling, general, and administrative expenses$20.9M+40.0% YoYR&D Expense HistoryResearch and development spending$7.7M+139.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$0Income Tax HistoryTotal income tax expense-$619.5K+8.5% YoYEPS (Basic) HistoryBasic earnings per share-$0.19